Evidence mapPaperPMID 41776235Full record

ArticleNPJ digital medicine2026

Virtual reality interventions for attention deficit/hyperactivity disorder: a systematic review.

Yujie Cao, Leilei Ma, Ningyu Liu, Jiali Wang, Charlotte Walton, Yanpei Wang

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yujie CaoState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Leilei MaState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Ningyu LiuState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Jiali WangState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China.
Charlotte WaltonSchool of Psychology, University of Southampton, Southampton, UK.
Yanpei WangState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China. wyp@bnu.edu.cn.

Funding

Brain Science and Brain-like Intelligence Technology-National Science and Technology Major Project 2021ZD0200500China Postdoctoral Science Foundation 2022M720487Fundamental Research Funds for the Central Universities 2022NTST13National Natural Science Foundation of China 32200873
6 · The paper itself

Abstract

Virtual reality (VR) interventions have emerged as innovative approaches increasingly used to manage attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. This systematic review included 22 randomized controlled trials, quasi-experimental, and open-label studies published between 2001 and 2025, comprehensively evaluating the feasibility of VR interventions, their effectiveness alone or combined with pharmacological treatment, the relative efficacy of different training modalities, and dosage-related factors. The results indicate that VR interventions, whether used independently or alongside medication, significantly improve core ADHD symptoms, executive functions, emotional regulation, and social skills, with long-term interventions (≥8 weeks) producing more pronounced and sustained benefits. Among the training modalities, interactive game training was the most frequently studied, followed by virtual scenario and exergaming, each demonstrating distinct effects on cognitive and behavioral outcomes. Overall, VR interventions generally demonstrated high adherence rates; however, adherence reporting was inconsistent across studies, and adverse effects were typically mild and transient. Future research should focus on large-scale randomized controlled trials employing standardized outcome measures and developing personalized VR protocols to further enhance treatment efficacy and clinical applicability for ADHD.

Identifiers

PMID41776235
PMCPMC13066543

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.